HEADER TOXIN 09-AUG-20 7JPM TITLE THE SOLUTION STRUCTURE OF OMEGA-THERAPHOTOXIN-PM1B ISOLATED FROM KING TITLE 2 BABOON SPIDER COMPND MOL_ID: 1; COMPND 2 MOLECULE: OMEGA-THERAPHOTOXIN-PM1B; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: PELINOBIUS MUTICUS; SOURCE 4 ORGANISM_COMMON: KING BABOON SPIDER; SOURCE 5 ORGANISM_TAXID: 753628 KEYWDS INHIBITOR, CYSTEIN KNOT, VOLTAGE-GATED SODIUM CHANNEL MODULATOR, KEYWDS 2 TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.K.-Y.CHIN,R.ZIEGMAN,P.F.ALEWOOD REVDAT 3 23-OCT-24 7JPM 1 REMARK REVDAT 2 11-OCT-23 7JPM 1 JRNL REVDAT 1 08-SEP-21 7JPM 0 JRNL AUTH R.K.FINOL-URDANETA,R.ZIEGMAN,Z.DEKAN,J.R.MCARTHUR, JRNL AUTH 2 S.HEITMANN,K.LUNA-RAMIREZ,H.S.TAE,A.MUELLER,H.STAROBOVA, JRNL AUTH 3 Y.K.CHIN,J.S.WINGERD,E.A.B.UNDHEIM,B.CRISTOFORI-ARMSTRONG, JRNL AUTH 4 A.P.HILL,V.HERZIG,G.F.KING,I.VETTER,L.D.RASH,D.J.ADAMS, JRNL AUTH 5 P.F.ALEWOOD JRNL TITL MULTITARGET NOCICEPTOR SENSITIZATION BY A PROMISCUOUS JRNL TITL 2 PEPTIDE FROM THE VENOM OF THE KING BABOON SPIDER. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 35074873 JRNL DOI 10.1073/PNAS.2110932119 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JPM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251199. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM BKTX, 20 MM SODIUM REMARK 210 PHOSPHATE, 5 % D2O, 95% H2O/5% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D 1H-1H TOCSY; 2D 1H REMARK 210 -15N HSQC; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, CCPNMR ANALYSIS, TOPSPIN, REMARK 210 TALOS REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 21 164.85 -48.58 REMARK 500 1 LYS A 29 177.55 -56.22 REMARK 500 2 LYS A 15 -41.79 -139.84 REMARK 500 2 CYS A 21 164.87 -49.12 REMARK 500 2 LYS A 29 177.60 -55.96 REMARK 500 3 LYS A 15 -41.07 -135.41 REMARK 500 3 CYS A 21 164.78 -49.41 REMARK 500 3 LYS A 29 177.54 -55.97 REMARK 500 3 ASP A 37 112.40 -163.65 REMARK 500 4 LYS A 15 -41.45 -139.02 REMARK 500 4 ASP A 37 44.39 -101.13 REMARK 500 5 LYS A 15 -41.60 -141.72 REMARK 500 5 CYS A 21 164.53 -48.53 REMARK 500 5 HIS A 31 65.09 60.08 REMARK 500 6 LYS A 15 -41.43 -138.59 REMARK 500 6 CYS A 21 164.76 -48.51 REMARK 500 6 LYS A 29 174.77 -54.80 REMARK 500 6 HIS A 31 67.18 -115.12 REMARK 500 7 LYS A 15 -41.93 -143.82 REMARK 500 7 CYS A 21 164.75 -49.20 REMARK 500 7 LYS A 29 177.77 -56.14 REMARK 500 8 LYS A 15 -41.86 -143.13 REMARK 500 8 CYS A 21 164.41 -49.63 REMARK 500 8 LYS A 29 175.14 -55.49 REMARK 500 9 LYS A 15 -41.63 -140.41 REMARK 500 9 CYS A 21 165.10 -49.34 REMARK 500 9 LYS A 29 170.45 -52.51 REMARK 500 9 ASP A 37 51.55 -97.74 REMARK 500 10 LYS A 15 -40.35 -133.46 REMARK 500 10 CYS A 21 164.79 -49.44 REMARK 500 11 CYS A 21 164.76 -49.93 REMARK 500 11 LYS A 29 176.82 -55.88 REMARK 500 12 LYS A 15 -41.82 -141.61 REMARK 500 12 CYS A 21 165.12 -49.36 REMARK 500 12 LYS A 29 179.40 -57.31 REMARK 500 13 CYS A 21 165.06 -49.18 REMARK 500 13 ASP A 37 42.12 -94.35 REMARK 500 14 CYS A 21 165.40 -49.36 REMARK 500 15 LYS A 15 -42.00 -144.36 REMARK 500 15 CYS A 21 165.15 -49.57 REMARK 500 15 LYS A 29 177.73 -55.94 REMARK 500 16 LYS A 15 -41.80 -143.85 REMARK 500 16 LYS A 29 178.26 -56.56 REMARK 500 16 ASP A 37 51.93 -96.44 REMARK 500 17 LYS A 15 -41.72 -139.13 REMARK 500 17 CYS A 21 165.20 -49.45 REMARK 500 18 LYS A 15 -41.61 -140.84 REMARK 500 19 ARG A 8 173.83 -55.82 REMARK 500 19 LYS A 15 -40.52 -133.72 REMARK 500 20 LYS A 15 -41.85 -140.45 REMARK 500 REMARK 500 THIS ENTRY HAS 52 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30785 RELATED DB: BMRB REMARK 900 THE SOLUTION STRUCTURE OF OMEGA-THERAPHOTOXIN-PM1B ISOLATED FROM REMARK 900 KING BABOON SPIDER DBREF 7JPM A 1 42 PDB 7JPM 7JPM 1 42 SEQRES 1 A 42 GLY VAL ASP LYS PRO GLY CYS ARG TYR LEU PHE GLY GLY SEQRES 2 A 42 CYS LYS SER ASP ASP ASP CYS CYS PRO ARG LEU GLY CYS SEQRES 3 A 42 LYS GLY LYS GLY HIS ASP TYR CYS ALA TRP ASP GLY THR SEQRES 4 A 42 PHE SER ASP SHEET 1 AA1 2 LEU A 24 CYS A 26 0 SHEET 2 AA1 2 CYS A 34 TRP A 36 -1 O ALA A 35 N GLY A 25 SSBOND 1 CYS A 7 CYS A 21 1555 1555 1.99 SSBOND 2 CYS A 14 CYS A 26 1555 1555 2.00 SSBOND 3 CYS A 20 CYS A 34 1555 1555 1.99 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 TER 588 ASP A 42 ENDMDL MODEL 2 TER 588 ASP A 42 ENDMDL MODEL 3 TER 588 ASP A 42 ENDMDL MODEL 4 TER 588 ASP A 42 ENDMDL MODEL 5 TER 588 ASP A 42 ENDMDL MODEL 6 TER 588 ASP A 42 ENDMDL MODEL 7 TER 588 ASP A 42 ENDMDL MODEL 8 TER 588 ASP A 42 ENDMDL MODEL 9 TER 588 ASP A 42 ENDMDL MODEL 10 TER 588 ASP A 42 ENDMDL MODEL 11 TER 588 ASP A 42 ENDMDL MODEL 12 TER 588 ASP A 42 ENDMDL MODEL 13 TER 588 ASP A 42 ENDMDL MODEL 14 TER 588 ASP A 42 ENDMDL MODEL 15 TER 588 ASP A 42 ENDMDL MODEL 16 TER 588 ASP A 42 ENDMDL MODEL 17 TER 588 ASP A 42 ENDMDL MODEL 18 TER 588 ASP A 42 ENDMDL MODEL 19 TER 588 ASP A 42 ENDMDL MODEL 20 TER 588 ASP A 42 ENDMDL CONECT 84 281 CONECT 192 355 CONECT 271 473 CONECT 281 84 CONECT 355 192 CONECT 473 271 MASTER 142 0 0 0 2 0 0 6 313 1 6 4 END